A rough look at the COVID-19 vaccine response in the Fluoroquinolone population from the limited data received.
Qui Tam Lawsuit Filed by Dr. Bennett against Johnson & Johnson, Bayer, Merck
COVID-19 post-viral sequelae, aka the "Long Haulers," is being complicated by the fact that many ill COVID-19 patients are being given a fluoroquinolone and steroid combination.
The fluoroquinolone antibiotics have the ability to reach yet to be discovered pathogenic genetic variants before we have had a chance to research their ability to cause potential harm.
Scientists have been tinkering with the fluoroquinolone family of antibiotics to try and find a herbicide replacement for glyphosate.
For the Food and Drug Administration it doesn’t matter how many people’s lives are utterly destroyed, just as long as some lives are saved and a disproportionate profit is earned.
If you have to take a fluoroquinolone antibiotic, is there anything you can do to take it safely and reduce your chances of having an adverse event?
For those new to Fluoroquinolone Toxicity try to avoid these psychological pitfalls which can hamper your progress.
Recently the East Virginia Medical School's (EVMS) released the Critical Care COVID-19 Management Protocol. This helpful guide also contains some preventative (prophylaxis) supplement tips.
History is replete with lessons that caution against resorting to haste in times of desperation because during these times well-meaning cures can become the cure that kills instead.
There is a thread of idiosyncratic toxicity that is poorly understood that spreads out like a crack in the foundation and loosely affects all of the drugs based off of this platform.
Chloroquine is being used to treat the coronavirus COVID-19. Is this drug safe to take after suffering FQ Toxicity?
One pill or one thousand thousand, for each person the threshold is different. But make no bones about it, there is a threshold for each person. A line, that once it is crossed, there is no going back.
Pharmaceutical research since 2009 as shown that quinolone molecules are suitable for designing newer derivatives against influenza viruses based upon promising antiviral activity seen.
Academic research is just now incidentally scratching the surface on the subject of delayed adverse events, or late fluoroquinolone effects.